1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of LOXL1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LOXL1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO RGD:1308752 6480464 1-Naphthylisothiocyanate results in increased expression of LOXL1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of LOXL1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1308752 6480464 Ethinyl Estradiol results in decreased expression of LOXL1 mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LOXL1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1318705 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LOXL1 mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol multiple interactions ISO RGD:1308752 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LOXL1 mRNA CTD PMID:32741896 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of LOXL1 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1318705 6480464 Estradiol results in increased expression of LOXL1 mRNA CTD PMID:19619570 more ... 17beta-estradiol 3-benzoate multiple interactions ISO RGD:1308752 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LOXL1 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1318705 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LOXL1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1308752 6480464 Tetrachlorodibenzodioxin affects the expression of LOXL1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LOXL1 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LOXL1 mRNA CTD PMID:27562557 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1308752 6480464 Tetrachlorodibenzodioxin results in increased expression of LOXL1 mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LOXL1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1318705 6480464 Tetrachlorodibenzodioxin results in decreased expression of LOXL1 mRNA CTD PMID:19619570 2,5-hexanedione multiple interactions ISO RGD:1308752 6480464 2 more ... CTD PMID:22382377 2,5-hexanedione increases expression ISO RGD:1308752 6480464 2, 5-hexanedione results in increased expression of LOXL1 protein CTD PMID:22382377 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1308752 6480464 3 more ... CTD PMID:20959002 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1318705 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of LOXL1 mRNA CTD PMID:16997883 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LOXL1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol affects expression EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of LOXL1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1318705 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of LOXL1 gene CTD PMID:31601247 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1318705 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of LOXL1 gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of LOXL1 exon CTD PMID:33297965 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of LOXL1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of LOXL1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression ISO RGD:1308752 6480464 Propylthiouracil results in increased expression of LOXL1 mRNA CTD PMID:24780913 8-Br-cAMP multiple interactions ISO RGD:1318705 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of LOXL1 mRNA CTD PMID:16997883 acetamide increases expression ISO RGD:1308752 6480464 acetamide results in increased expression of LOXL1 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1308752 6480464 Acrylamide results in decreased expression of LOXL1 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1318705 6480464 Aflatoxin B1 results in increased expression of LOXL1 mRNA CTD PMID:21641981 all-trans-retinoic acid multiple interactions EXP 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of LOXL1 mRNA more ... CTD PMID:30951980 antimycin A decreases expression ISO RGD:1318705 6480464 Antimycin A results in decreased expression of LOXL1 mRNA CTD PMID:33512557 antirheumatic drug increases expression ISO RGD:1318705 6480464 Antirheumatic Agents results in increased expression of LOXL1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1318705 6480464 aristolochic acid I results in increased expression of LOXL1 mRNA CTD PMID:33212167 azoxystrobin decreases expression ISO RGD:1318705 6480464 azoxystrobin results in decreased expression of LOXL1 mRNA CTD PMID:33512557 benzalkonium chloride decreases expression EXP 6480464 Benzalkonium Compounds results in decreased expression of LOXL1 mRNA CTD PMID:31199489 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of LOXL1 mRNA CTD PMID:21569818 benzo[a]pyrene affects methylation ISO RGD:1318705 6480464 Benzo(a)pyrene affects the methylation of LOXL1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1318705 6480464 Benzo(a)pyrene results in increased methylation of LOXL1 5' UTR, Benzo(a)pyrene results in increased methylation of LOXL1 exon CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of LOXL1 mRNA CTD PMID:15034205 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of LOXL1 mRNA] CTD PMID:15034205 Benzo[ghi]perylene increases expression EXP 6480464 1, 12-benzoperylene results in increased expression of LOXL1 mRNA CTD PMID:26377693 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of LOXL1 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions ISO RGD:1308752 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LOXL1 mRNA CTD PMID:18164116 bisphenol A affects expression ISO RGD:1308752 6480464 bisphenol A affects the expression of LOXL1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of LOXL1 mRNA CTD PMID:30951980 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LOXL1 mRNA CTD PMID:30951980 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of LOXL1 mRNA CTD PMID:30951980 bisphenol F multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of LOXL1 mRNA CTD PMID:30951980 cadmium atom decreases expression ISO RGD:1318705 6480464 Cadmium results in decreased expression of LOXL1 mRNA CTD PMID:21120746 cadmium dichloride decreases expression ISO RGD:1318705 6480464 Cadmium Chloride results in decreased expression of LOXL1 mRNA CTD PMID:26472689 calcitriol decreases expression ISO RGD:1318705 6480464 Calcitriol results in decreased expression of LOXL1 mRNA CTD PMID:26485663 carbamazepine affects expression ISO RGD:1318705 6480464 Carbamazepine affects the expression of LOXL1 mRNA CTD PMID:25979313 carbendazim increases expression ISO RGD:1308752 6480464 carbendazim results in increased expression of LOXL1 protein CTD PMID:22382377 carbendazim multiple interactions ISO RGD:1308752 6480464 2 more ... CTD PMID:22382377 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carmustine decreases expression ISO RGD:1318705 6480464 Carmustine results in decreased expression of LOXL1 mRNA CTD PMID:15980968 CGP 52608 multiple interactions ISO RGD:1318705 6480464 CGP 52608 promotes the reaction [RORA protein binds to LOXL1 gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:1308752 6480464 Chloroprene results in decreased expression of LOXL1 mRNA CTD PMID:23125180 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of LOXL1 mRNA CTD PMID:23125180 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of LOXL1 more ... CTD PMID:20938992 copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOXL1 mRNA CTD PMID:15467011 copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOXL1 mRNA CTD PMID:15467011 cumene decreases expression EXP 6480464 cumene results in decreased expression of LOXL1 mRNA CTD PMID:18648096 Cuprizon increases expression ISO RGD:1308752 6480464 Cuprizone results in increased expression of LOXL1 mRNA CTD PMID:26577399 deguelin decreases expression ISO RGD:1318705 6480464 deguelin results in decreased expression of LOXL1 mRNA CTD PMID:33512557 dexamethasone decreases expression ISO RGD:1308752 6480464 Dexamethasone results in decreased expression of LOXL1 mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:1308752 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LOXL1 mRNA] CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:1318705 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of LOXL1 mRNA CTD PMID:16997883 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LOXL1 mRNA CTD PMID:29950665 diazinon decreases methylation ISO RGD:1318705 6480464 Diazinon results in decreased methylation of LOXL1 gene CTD PMID:22964155 diuron decreases expression ISO RGD:1308752 6480464 Diuron results in decreased expression of LOXL1 mRNA CTD PMID:25152437 doxorubicin decreases expression ISO RGD:1318705 6480464 Doxorubicin results in decreased expression of LOXL1 mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:1308752 6480464 Endosulfan results in increased expression of LOXL1 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1318705 6480464 entinostat results in increased expression of LOXL1 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:1308752 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of LOXL1 mRNA CTD PMID:17347304 ethanol increases expression ISO RGD:1318705 6480464 Ethanol results in increased expression of LOXL1 mRNA CTD PMID:28986285 ethanol multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LOXL1 mRNA CTD PMID:30517762 fenpyroximate decreases expression ISO RGD:1318705 6480464 fenpyroximate results in decreased expression of LOXL1 mRNA CTD PMID:33512557 fenvalerate increases expression ISO RGD:1308752 6480464 fenvalerate results in increased expression of LOXL1 mRNA CTD PMID:30307764 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 fulvestrant multiple interactions ISO RGD:1318705 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of LOXL1 gene CTD PMID:31601247 furan increases expression ISO RGD:1308752 6480464 furan results in increased expression of LOXL1 mRNA CTD PMID:27387713 gentamycin decreases expression ISO RGD:1308752 6480464 Gentamicins results in decreased expression of LOXL1 mRNA CTD PMID:22061828 hydrogen peroxide affects expression ISO RGD:1318705 6480464 Hydrogen Peroxide affects the expression of LOXL1 mRNA CTD PMID:20044591 indole-3-methanol multiple interactions ISO RGD:1308752 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LOXL1 mRNA CTD PMID:22129741 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of LOXL1 more ... CTD PMID:20938992 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of LOXL1 mRNA CTD PMID:19751817 microcystin-LR increases expression ISO RGD:1308752 6480464 cyanoginosin LR results in increased expression of LOXL1 mRNA CTD PMID:34740672 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of LOXL1 mRNA CTD PMID:22078008 Muraglitazar decreases expression ISO RGD:1308752 6480464 muraglitazar results in decreased expression of LOXL1 mRNA CTD PMID:21515302 N-methyl-4-phenylpyridinium increases expression ISO RGD:1318705 6480464 1-Methyl-4-phenylpyridinium results in increased expression of LOXL1 mRNA CTD PMID:24810058 N-nitrosodiethylamine multiple interactions ISO RGD:1308752 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LOXL1 mRNA more ... CTD PMID:18164116 more ... oxaliplatin increases expression ISO RGD:1308752 6480464 oxaliplatin results in increased expression of LOXL1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:1308752 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LOXL1 mRNA CTD PMID:25729387 picoxystrobin decreases expression ISO RGD:1318705 6480464 picoxystrobin results in decreased expression of LOXL1 mRNA CTD PMID:33512557 potassium chromate decreases expression ISO RGD:1318705 6480464 potassium chromate(VI) results in decreased expression of LOXL1 mRNA CTD PMID:22714537 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of LOXL1 mRNA CTD PMID:23608068 pyrimidifen decreases expression ISO RGD:1318705 6480464 pyrimidifen results in decreased expression of LOXL1 mRNA CTD PMID:33512557 rotenone decreases expression ISO RGD:1308752 6480464 Rotenone results in decreased expression of LOXL1 mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:1318705 6480464 Rotenone results in decreased expression of LOXL1 mRNA CTD PMID:33512557 silicon dioxide increases expression ISO RGD:1318705 6480464 Silicon Dioxide analog results in increased expression of LOXL1 mRNA CTD PMID:23806026 silicon dioxide decreases expression ISO RGD:1308752 6480464 Silicon Dioxide results in decreased expression of LOXL1 mRNA CTD PMID:22431001 sodium arsenite affects methylation ISO RGD:1318705 6480464 sodium arsenite affects the methylation of LOXL1 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:1318705 6480464 sodium arsenite results in increased expression of LOXL1 mRNA CTD PMID:28595984 , PMID:34032870 Soman increases expression ISO RGD:1308752 6480464 Soman results in increased expression of LOXL1 mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:1318705 6480464 Sunitinib results in decreased expression of LOXL1 mRNA CTD PMID:31533062 tebufenpyrad decreases expression ISO RGD:1318705 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of LOXL1 mRNA CTD PMID:33512557 testosterone multiple interactions ISO RGD:1308752 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LOXL1 mRNA, Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LOXL1 mRNA] CTD PMID:20032058 , PMID:32741896 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of LOXL1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LOXL1 mRNA CTD PMID:30517762 thifluzamide decreases expression ISO RGD:1318705 6480464 thifluzamide results in decreased expression of LOXL1 mRNA CTD PMID:33512557 thioacetamide multiple interactions ISO RGD:1308752 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LOXL1 mRNA CTD PMID:28943392 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LOXL1 mRNA CTD PMID:29950665 topotecan increases expression ISO RGD:1308752 6480464 Topotecan results in increased expression of LOXL1 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:1308752 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LOXL1 mRNA CTD PMID:25729387 Trapidil multiple interactions ISO RGD:1308752 6480464 Trapidil affects the reaction [PTH protein affects the expression of LOXL1 mRNA] CTD PMID:18635661 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of LOXL1 mRNA CTD PMID:19042947 valproic acid affects expression ISO RGD:1318705 6480464 Valproic Acid affects the expression of LOXL1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1318705 6480464 Valproic Acid results in increased expression of LOXL1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid decreases expression ISO RGD:1318705 6480464 Valproic Acid results in decreased expression of LOXL1 mRNA CTD PMID:29154799 valproic acid increases methylation ISO RGD:1318705 6480464 Valproic Acid results in increased methylation of LOXL1 gene CTD PMID:29154799 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of LOXL1 mRNA CTD PMID:18930951 vinclozolin affects expression ISO RGD:1308752 6480464 vinclozolin affects the expression of LOXL1 mRNA CTD PMID:19015723